subject

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

December 10, 2025 18:00 ET  | Source: Fortrea Holdings Inc DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq:…

6 days ago

SABTNL (Aqylon Nexus Limited) Signs MoU with Telangana for INR 4,000-Crore AI & Green Data Centre Backed by Global Investment Funds

Sri Adhikari Brothers Television Network Limited (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN: INE416A01044), which is in the process of being renamed…

7 days ago

NOTICE TO DISREGARD — ICARO Media Group

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- We are advised by ICARO that certain information is subject to confidentiality agreements.…

1 week ago

Accord Healthcare Announces Launch of Denosumab – Second Biosimilar in Bone Health

∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.LONDON, Dec. 2, 2025 /PRNewswire/…

2 weeks ago

Markel International appoints Rohan Davies as Managing Director of new London Market business

LONDON, Nov. 13, 2025 /PRNewswire/ -- Markel Insurance, the insurance operation within Markel Group Inc. (NYSE: MKL), today announced the…

1 month ago

Rocket Doctor Grants RSUs and Stock Options

Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor…

1 month ago

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2025 16:41 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

2 months ago

LIS Technologies Inc. Appoints Subject Matter Expert John Olvera as its Integrated Safety Analysis Manager

Oak Ridge, Tennessee, Aug. 22, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced…

4 months ago

Intas & Accord signs Agreement to acquire Prothya Biosolutions

AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of…

4 months ago